Net Income (Quarterly) Chart

Historical Net Income (Quarterly) Data

View and export this data back to 2017. Start Trial.
Date Value
June 30, 2026 -109.90M
March 31, 2026 -105.51M
December 31, 2025 -90.96M
September 30, 2025 -102.22M
June 30, 2025 -110.03M
March 31, 2025 -74.72M
December 31, 2024 -66.45M
September 30, 2024 -64.48M
June 30, 2024 -58.51M
March 31, 2024 -56.85M
December 31, 2023 -46.13M
September 30, 2023 -42.36M
June 30, 2023 -37.92M
March 31, 2023 -39.38M
December 31, 2022 -39.26M
September 30, 2022 -43.30M
June 30, 2022 -44.00M
March 31, 2022 -7.95M
December 31, 2021 -35.91M
Date Value
September 30, 2021 -37.51M
June 30, 2021 -30.71M
March 31, 2021 -27.67M
December 31, 2020 -26.57M
September 30, 2020 -23.56M
June 30, 2020 -19.28M
March 31, 2020 -17.07M
December 31, 2019 -11.57M
September 30, 2019 -16.15M
June 30, 2019 -12.52M
March 31, 2019 -10.76M
December 31, 2018 -14.97M
September 30, 2018 -10.76M
June 30, 2018 -14.71M
March 31, 2018 -8.892M
December 31, 2017 -8.457M
September 30, 2017 -5.929M
June 30, 2017 -5.879M
March 31, 2017 -4.73M

Net Income Definition

Represents net income for the period and date(s) requested in local currency by default.

Read full definition.

Net Income (Quarterly) Range, Past 5 Years

View Net Income (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Net Income (Quarterly) Benchmarks

View Net Income (Quarterly) Benchmarks
Start Trial
Agenus, Inc. -0.567M
Amgen, Inc. 2.375B
BioCryst Pharmaceuticals, Inc. 78.40M
Imunon, Inc. -2.814M
Curis, Inc. -8.581M

Net Income (Quarterly) Related Metrics